ASH: Lilly’s Jaypirca Looks Headed For The Front Line

 
• By Alaric DeArment
  
Eli Lilly's booth at the 2025 ASH meeting (Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASH

More from Conferences